Steven J. Chmura, MD, PhD, associate professor in the Department of Radiation and Cellular Oncology, will present “Hunting the Yeti: A decade in search of Oligometastases and the Abscopal Effect.”
The director of Clinical and Translational Research for Radiation Oncology at the University of Chicago for over a decade, Chmura has been actively involved in both the clinical implementation of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) and related translational and clinical research, as well as the integration of SRS and SBRT into other systemic therapies. His clinical interests include breast cancer, limited metastatic disease, immunotherapy, and technologic improvements in the delivery of radiotherapy.
Chmura is an active member of the NCI cooperative group, NRG Oncology, serving on the committee for Breast Cancer and also as the liaison to the Radiation Oncology division. These efforts have led to the first international trials through NRG Oncology examining the safety of treating breast cancer patients with three to four metastases as well as a Phase II/III trial examining potential improvements to progression-free survival and overall survival. Chmura's work in radio-immunology has also translated into multiple investigator-sponsored trials along with the now accruing NCI-sponsored (A091605) trial randomizing the role of SBRT combined with pembrolizumab in advanced Merkel cell carcinoma. This integration of ablative radiotherapy and immunotherapy along with advancing the search for biomarkers is his current focus.
Chmura's lecture begins at 8:10 a.m. and ends at 9 a.m. His address will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. The April DCI Seminar Series is presented by the DCI Women’s Cancer Program. Duke Cancer Institute members are invited to attend.
Jones Building, room 143.
For more information, contact Erin Carr.